Focusing on the Future of Wellness: Renhe Capsule Launches New Intelligent Plant-Based Capsule Production Line, Annual Capacity Exceeds 20 Billion Units

In response to global market trends such as vegetarianism, clean labeling, and allergen sensitivity, as well as to meet the growing demand for plant-based capsules, Shaoxing Renhe Capsule Co., Ltd. recently announced the official launch and operation of its new intelligent hydroxypropyl methylcellulose (HPMC) plant-based capsule production line. The completion of this production line represents a significant leap in Renhe's annual production capacity for plant-based capsules, reaching a scale of 20 billion units. This milestone underscores the company's strategic commitment and delivery capabilities in the core excipient sector of the global health industry.

The new production line incorporates industry-leading intelligent control systems and integrated clean production equipment, enabling fully automated and digital management of the entire process—from raw material dissolution, precision dipping, drying, and shaping to sorting and packaging. Compared to traditional production lines, this advancement has significantly improved production efficiency and product uniformity while substantially reducing energy consumption per unit. It ensures that key performance indicators such as product stability, disintegration performance, and low moisture content meet top international standards.

“The launch of this production line is a crucial milestone in our ‘Green and Intelligent’ strategic initiative,” stated the Production General Manager of Renhe Capsule. “It not only enables the production of HPMC capsules in standard specifications but also allows us to rapidly respond to customers’ flexible production needs, including niche sizes, customized colors, and tailored formulations. This provides stronger and more agile supply chain support for global health products, functional foods, and innovative pharmaceutical clients.”

Capacity Expansion: From Scale Advantage to Technological Leadership

This expansion of production capacity not only solidifies Renhe Capsule’s leading position in the domestic plant-based capsule market but also lays a solid production foundation for serving international mainstream brands and becoming a trusted core supplier for global health companies. Through continuous R&D investment, the production line integrates advanced technologies such as low-moisture control systems, non-adhesive sorting mechanisms, and online quality monitoring platforms. These innovations not only enhance production capacity but also achieve breakthroughs in traceable quality control and low-carbon production. The production line has already passed on-site audits for multiple international quality systems and is capable of producing products that comply with global market access standards, including the U.S. FDA, EU EDQM, and Islamic Halal certifications.

Future Planning: Responding to Global Health Trends with Green and Intelligent Manufacturing

Against the backdrop of rapid global growth in the health industry, plant-based capsules—with their advantages of being non-animal-derived, allergen-free, and highly stable—are becoming a vital direction for dosage form innovation. The launch of Renhe Capsule’s new production line is a key initiative in the company’s forward-looking strategy to build a green supply chain and align with sustainable development principles. Moving forward, the company will continue to advance the R&D and application of plant-based capsules in specialized dosage forms, functional composites, and intelligent release systems. Together with global partners, Renhe Capsule will explore new capsule solutions that are safer, more environmentally friendly, and better suited to personalized health needs.